Investigating how anti-malarial treatments during pregnancy and childhood affect growth in children
Official title: Evaluating the causal effects of anti-malarial chemoprevention in pregnancy and childhood on growth outcomes
Funded at Stanford University · NIH-11081619 · Data updated 2026-11-12
This study is looking at how giving anti-malarial treatments to pregnant women and young children can help reduce malaria and improve the growth of kids under five in sub-Saharan Africa.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | April 11, 2024 |
| Project end | August 10, 2026 |
| Funding year | 2025 |
| Award (this year) | $48,974 |
| NIH project number | 5F31AI179107-02 |
| Project ID | NIH-11081619 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant women and children under the age of five living in high malaria transmission areas.
✕Less likely to help
Patients who are not pregnant or do not have children under five years old may not benefit from this research.
What this research studies
This research focuses on understanding the impact of anti-malarial chemoprevention on the growth outcomes of children under five years old in sub-Saharan Africa. It aims to evaluate how intermittent preventive treatments given to pregnant women and young children can reduce malaria infections and improve growth metrics. By analyzing the relationship between malaria, inflammation, and gut health, the study seeks to identify effective interventions that could enhance child health and development. The methodology includes systematic assessments of growth outcomes in relation to these treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved growth and health outcomes for children at risk of malaria in sub-Saharan Africa.
How similar studies have gone: Previous research has shown that anti-malarial treatments can effectively reduce malaria infections, but this study aims to explore their specific impact on child growth outcomes, making it a novel approach.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Nguyen, Anna Thuy Nhu — Stanford University
- Study coordinator: Nguyen, Anna Thuy Nhu
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.